茚达特罗上市剂量选择的论战：美国FDA定量药理学审评的故事
尹 芳，王玉珠，郑青山
Dose selection of indacaterol for marketing approval: a FDA story in pharmacometrics review
YIN Fang, WANG Yuzhu, ZHENG Qingshan
中国临床药理学与治疗学
.
2018, (9): 1031
-1039
.
DOI: 10.12092/j.issn.1009-2501.2018.09.011
